Vascular endothelial growth factor contributes to lung vascular hyperpermeability in sepsis-associated acute lung injury.

导出 OA

翻译打印收藏纠错

第一作者： Kengo,Tomita

第一单位： Department of Molecular and Medical Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan.

作者： Kengo,Tomita ^[1] ; Yuna,Saito ^[2] ; Tokiko,Suzuki ^[1] ; Samar,Imbaby ^[3] ; Kohshi,Hattori ^[1] ; Naoyuki,Matsuda ^[4] ; Yuichi,Hattori ^[1]

作者单位： Department of Molecular and Medical Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan. ^[1] Medical Environment Engineering Group, Center for Environmental Engineering, Shimizu Corporation, Institute of Technology, Tokyo, 135-0044, Japan. ^[2] Center for Clinical Training, Juntendo University Urayasu Hospital, Urayasu, 279-0021, Japan. ^[3] J-Pharma Co., Ltd., Yokohama, 230-0046, Japan. ^[4] Department of Clinical Pharmacology, Faculty of Medicine, Suez Canal University, Ismailia, 41522, Egypt. ^[5] Department of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, Tokyo, 113-8655, Japan. ^[6] Department of Emergency and Critical Care Medicine, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan. ^[7] Department of Molecular and Medical Pharmacology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, 930-0194, Japan. yhattori.med@ivory.plala.or.jp. ^[8] Advanced Research Promotion Center, Health Sciences University of Hokkaido, Tobetsu, 061-0293, Japan. yhattori.med@ivory.plala.or.jp. ^[9]

关键词 Acute lung injury Pulmonary microvascular endothelial cell Pulmonary vascular permeability Sepsis Vascular endothelial growth factor (VEGF)